Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

NASDAQ:IRWD

0.77

+0.03 (+3.56%)

3:19:13 PM EDT: $0.72 -0.04 (-5.63%)

Market Cap (Intraday)	128.37M
Current PE	N/A
Forward PE	4.53
2yr Forward PE	2.2

See more stats

Estimates Current Quarter

Revenue	$62 Million
Adjusted EPS	$0.03

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A Stock, NASDAQ:IRWD

100 Summer Street, Suite 2300, Boston, Massachusetts 02110

United States of America

Phone: +1.617.621.7722

Number of Employees: 267

http://www.ironwoodpharma.com

Description

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.